Erythropoietin and prematurity - Where do we stand?

Journal of Perinatal Medicine

Volumn 33, Issue 4, 2005, Pages 277-286

  Carbonell Estrany, Xavier ^a,b   Figueras Aloy, Josep ^a   Alvarez, Enriqueta ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institut Clinic de Ginecologia   (Spain)

Author keywords

Anemia; Blood transfusion; Erythropoietin; Prematurity

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

BLOOD TRANSFUSION; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DOSE REGIMEN; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; NEWBORN ANEMIA; NUTRITIONAL STATUS; OUTCOMES RESEARCH; PHLEBOTOMY; PLACENTAL TRANSFER; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

ANEMIA, NEONATAL; BLOOD TRANSFUSION; CHILD DEVELOPMENT; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; PREGNANCY;

EID: 23944503842     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2005.054     Document Type: Review

References (77)

1. Al-Kharfy T, JA Smyth, L Wadsworth, G Krystal, C Fitzgerald, J Davis, R Milner: Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 129 (1996) 89
2. Anderson S, J Fangman, G Wager, D Uden: Retrieval of placental blood from the umbilical vein to determine volume, sterility and presence of clot formation. Am J Dis Child 146 (1992) 36
3. Asch J, JF Wedgwood: Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy? J Perinatol 17 (1997) 276
4. Ballin A, A Bilker-Reich, E Arbel, Y Davidovitz, D Kohelet: Erythropoietin, given enterally, stimulates erythropoiesis in premature infants. Lancet 353 (1999) 1849
5. Bard H, JA Widness: Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants. J Pediatr 127 (1995) 478
6. Bechensteen AG, P Haga, S Halvorsen, A Whitelaw, K Liestol, R Lindemann, et al.: Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child Fetal Neonatal Ed 69 (1993) 19
7. Bechensteen AG, P Haga, S Halvorsen, K Liestol, R Lindemann, A Whitelaw, et al.: Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake. Eur J Pediatr 156 (1997) 56
8. Bifano EM, TR Curran: Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects. Clin Perinatol 22 (1995) 657
9. Brown MS, H Shapiro: Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity. J Pediatr 128 (1996) 512
10. Carbonell Estrany X, J Figueras Aloy, JM Perez Fernández, A Fernández López, G Gonzalez Luis, MD Salvia Roiges: Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight. [Article in Spanish]. An Esp Pediatr 51 (1999) 281
11. Carbonell Estrany X, J Figueras Aloy: Anaemia of prematurity: treatment with erythropoietin. Early Hum Dev 65 (2001) S62
12. Casadevall N, J Nataf, B Viron, A Kolta, JJ Kiladjian, P Martin-Dupont, et al.: Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346 (2002) 469
13. De la Torre Aguilar MJ, FJ Gascón Jiménez, M Zapatero Martínez, J Guzmán Cabanas, D Huertas Muñoz, D Ruiz González, et al.: Prophylaxis of anemia of prematurity with erythropoietin. Case control study. [Article in Spanish]. An Esp Pediatr 53 (2000) 243
14. Donato H, N Vain, P Rendo, N Vivas, L Prudent, M Larguia, et al.: Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebocontrolled, multicenter trial. Pediatrics 105 (2000) 1066
15. Emmerson AJ, HJ Coles, CM Stern, TC Pearson: Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 68 (1993) 291
16. Emmerson AJB: Role of erythropoietin in the newborn. Arch Dis Child 69 (1993) 273
17. Eschbach JW, JC Egrie, MR Downing, JK Browne, JW Adamson: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316 (1987) 73
18. Figueras Aloy J, X Carbonell Estrany: Blood extractions, transfusion policy and erythropoietin in the newborn. [Article in Spanish]. An Esp Pediatr 49 (1998) 46
19. Franz AR, F Pohlandt: Red blood cel transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fet Neonat Ed 84 (2001) F96
20. Gallagher PG, RA Ehrenkranz: Erythropoietin therapy for anemia of prematurity. Clin Perinatol 20 (1993) 169
21. Goodnough LT, TG Monk, GL Andriole: Erythropoietin therapy. N Engl J Med 336 (1997) 933
22. Griffiths G, R Lall, S Chatfield, A Short, P Mackay, P Williamson, J Brown, MI Levene: Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 76 (1997) F190
23. Guyton AC: Tratado de Fisiología Médica. Interamericana. MacGraw-Hill, Madrid 1992
24. Halperin DS, M Felix, P Wacker, G Lacourt, JF Babel, M Wyss: Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr 151 (1992) 661
25. Halperin DS, P Wacker, G Lacourt, M Felix, JF Babel, M Aapro, M Wyss: Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 116 (1990) 779
26. Javier Manchon G, A Natal Pujol, W Coroleu Lletget, A Zuasnabar Cotro, J Badía Barnusell, J Junca Piera, et al.: Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity. [Article in Spanish]. An Esp Pediatr 46 (1997) 587
27. Juul S: Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr 91(Suppl) (2002) 36
28. Juul S: Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Clin Perinatol 31 (2004) 129
29. Juul SE, AE Joyce, Y Zhao, DJ Ledbetter: Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 46 (1999) 263
30. Juul SE, Y Zhao, JB Dame, Y Du, AD Hutson, RD Christensen: Origin and fate of erythropoietin in human milk. Pediatr Res 48 (2000) 660
31. Juul SE: Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates. J Pediatr 143 (2003) 321
32. Juul SE: Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin Perinatol 27 (2000) 527
33. Kling PJ, RL Schmidt, RA Roberts, JA Widness: Serum erythopoietin levels during infancy: association with erythropoiesis. J Pediatr 128 (1996) 791
34. Kotto-Kome AC, MG Garcia, DA Calhoun, RD Christensen: Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis. J Perinatol 24 (2004) 24
35. Kumral A, S Gonenc, O Acikgoz, A Sonmez, K Genc, O Yilmaz, et al.: Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hipoxic-ischemic brain injury in neonatal rats. Biol Neonate 87 (2005) 15
36. Lachance C, P Chessex, JC Fouron, JA Widness, H Bard: Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr 125 (1994) 278
37. Ledbetter DJ, SE Juul: Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 35 (2000) 178
38. Maier RF, M Obladen, E Kattner, J Natzschka, J Messer, BM Regazzoni, et al.: High- versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr 132 (1998) 866
39. Maier RF, M Obladen, I Muller-Hansen, E Kattner, U Merz, R Arlettaz, et al.: Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141 (2002) 8
40. Maier RF, M Obladen, P Scigalla, O Linderkamp, G Duc, G Hieronimi, et al.: The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in verylow-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 330 (1994) 1173
41. Meister B, A Khoss, G Burda, W Bock, M Kolmer, A Lischka, et al.: Decreasing reticulocyte counts associated with declining post-dose erythropoietin plasma levels in anaemia of prematurity. Biol Neonate 74 (1998) 409
42. Messer J, J Haddad, L Donato, D Astruc, J Matis J: Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 92 (1993) 519
43. Meyer MP, C Haworth, JH Meyer, A Commerford: A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 129 (1996) 258
44. Meyer MP, E Sharma, M Carsons: Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fet Neonat Ed 88 (2003) F41
45. Meyer MP, JH Meyer, A Commerford, FM Hann, AA Sive, G Moller, J Jacobs, AF Malan: Recombinant human erythropoietin in the treatment of anemia of prematurity: results of a double blind, placebo-controlled study. Pediatrics 93 (1994) 918
46. Obladen M, M Sachsenweger, M Stahnke: Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr 147 (1988) 399
47. Ohls RK, A Dai: Long-acting erythropoietin: clinical studies and potential uses in neonates. Clin Perinatol 31 (2004) 77
48. Ohls RK, J Harcum, KR Schibler, RD Christensen: The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, doubleblind, placebo-controlled study. J Pediatr 131 (1997) 661
49. Ohls RK, KW Liechty, MC Turner, R Kimura, RD Christensen: Erythroid "burst promoting" activity in serum of patients with the anemia of prematurity. J Pediatr 116 (1990) 786
50. Ohls RK, MW Veerman, RD Christensen: Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition. J Pediatr 128 (1996) 518
51. Ohls RK, RA Ehrenkranz, A Das, AM Dusick, K Yolton K, E Romano, et al.: Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114 (2004) 1287
52. Ohls RK, RA Ehrenkranz, LL Wright, JA Lemons, SB Korones, BK Stoll, et al: Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial. Pediatrics 108 (2001) 934
53. Ohls RK, RD Christensen: Recombinant erythopoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 119 (1991) 781
54. Ohls RK: Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediatr 141 (2002) 3
55. Oski FA, JL Naiman: Hematologic problems in the newborn. 3rd edition. Saunders, Philadelphia 1982
56. Perapoch Lopez J, J Castilla Crespi, T Llopart Moragas, D Castella Cahiz, S Salcedo Abizanda: Reduction of exposure to multiple donors in premature newborns weighing less than 1,500 g at birth. [Article in Spanish]. An Esp Pediatr 47 (1997) 551
57. Pollak A, M Hayde, M Hayn, K Herkner, KA Lombard, G Lubec, et al.: Effect of intravenous iron supplementation on erythropoiesis-treated premature infants. Pediatrics 107 (2001) 78
58. Rigourd V, F Kieffer, MA Dommergues, A Ayachi, Z Assaf, I Mohamed, M Voyer, JF Magny: Érythopoïetine chez le nouveau-né: efficacité comparée des vois d'administration sous-cutanée et intraveineuse. Archiv Pediatr 11 (2004) 319
59. Ringer SA, DK Richardson, RA Sacher, M Keszler,WH Churchill: Variations in transfusion practice in neonatal intensive care unit. Pediatrics 101 (1998) 194
60. Rodriguez-Miguelez JM: Transfusiones en el recién nacido. Arch Pediatr (Barc) 44 (1993) 90
61. Sastre Huerta E, B Alonso Alvarez, R Montero Alonso, T Alvarez Martín, F Barbadillo Izquierdo, I Carpintero Martín, et al.: Erythropoietin in anemia of the premature infant. Neonatal factors that are predictors of transfusión. [Article in Spanish]. An Esp Pediatr 49 (1998) 49
62. Schaffer AJ, ME Avery: Disease of newborn. 6th edition, Saunders, Philadelphia 1991
63. Shannon K: Recombinant human erythropoietin in neonatal anemia. Clin Perinatol 22 (1995) 627
64. Shannon KM, JF Keith 3rd, WC Mentzer, RA Ehrenkranz, MS Brown, JA Widness, et al.: Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95 (1995) 1
65. Shannon KM, WC Mentzer, RI Abels, P Freeman, N Newton, D Thompson, S Sniderman, R Ballard, RH Phibbs: Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 118 (1991) 949
66. Soubasi V, G Kremenopoulos, E Diamandi, C Tsantali, D Tsakiris: In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 34 (1993) 675
67. Soubasi V, G Kremenopoulos, E Diamanti, C Tsantali, K Sarafidis, D Tsakiris: Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 127 (1995) 291
68. Strauss RG.: Autologous transfusions for neonates using placental blood. A cautionary note. Am J Dis Child 146 (1992) 21
69. Strauss RG: Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea. J Pediatr 131 (1997) 653
70. Strauss RG: Red blood cell transfusion practices in the neonate. Clin Perinatol 22 (1995) 641
71. Vamvakas EC, RG Strauss: Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 41 (2001) 406
72. Voyer M, JF Magny: Prématurité. Monographie de l'Encyclopédia Médico-Chirurgicale. Elsevier, Paris 1998
73. Widness JA, KA Lombard, EE Ziegler, RE Serfass, SJ Carlson, KJ Johnson, et al.: Erythrocyte incorporation and absorption of 58Fe in premature infants treated with erythropoietin. Pediatr Res 41 (1997) 416
74. Wilimas JA, WM Crist: Erythopoietin - not yet a standard treatment for anemia of prematurity. Pediatrics 95 (1995) 9
75. Williamson P, G Griffiths, D Norfolk, M Levene: Blood transfusions and human recombinat erythopoietin in premature newborn infants. Arc Dis Child Fetal Neonatal Ed 75 (1996) F65
76. Zaffanello M, M Franchini, S Rugolotto: Recombinant human erythropoietin might induce strawberry haemangiomas in very-low-birthweight preterm infants. Acta Paediatr 92 (2003) 1353
77. Zipursky A: Erythropoietin therapy for premature infants: cost without benefit? Pediatr Res 48 (2000) 136